Key result
Diltiazem SR plus hydrochlorothiazide achieves goal BP in ~75% of patients, outperforming monotherapy.
RCT (n=297)
Factorial-design
Yes
Answers are grounded in this paper and cite their sources.
Randomized trial demonstrates additive blood pressure reduction with diltiazem and hydrochlorothiazide combination therapy in mild to moderate hypertension, highlighting enhanced control at higher...
This multicenter, factorial-design trial assessed the safety and additive antihypertensive efficacy of a slow-release (SR) formulation of diltiazem hydrochloride given alone or in combination with hydrochlorothiazide for treatment of mild to moderate hypertension. After a 4- to 6-week placebo run-in period, 297 qualifying patients were randomized to receive placebo, 1 of 4 doses of diltiazem SR monotherapy, 1 of 3 doses of hydrochlorothiazide monotherapy, or 1 of 12 possible combinations of diltiazem SR and hydrochlorothiazide for 6 weeks. A dose-related reduction in blood pressure was demonstrated for each drug as monotherapy and for the two drugs in combination. Absolute blood pressures of patients who received combination therapy were lower by an overall mean of 3.0 mm Hg diastolic and 8.0 mm Hg systolic vs diltiazem SR used alone and 3.5 mm Hg diastolic and 4.0 mm Hg systolic vs hydrochlorothiazide used alone. At the largest doses used, 50% of patients achieved goal blood pressure while taking hydrochlorothiazide, 57% while taking diltiazem SR, and 75% while taking combination therapy. Combination therapy was well tolerated. This trial clearly demonstrates that diltiazem SR and hydrochlorothiazide have additive antihypertensive effects.
No takes yet. Share an insight, caveat, or question.
James F. Burris (1990) conducted an RCT in Mild to moderate hypertension (n=297). Diltiazem SR and hydrochlorothiazide combination therapy vs. Placebo, diltiazem SR monotherapy (4 doses), or hydrochlorothiazide monotherapy (3 doses) was evaluated on Blood pressure reduction and achievement of goal blood pressure (MD -8.0/-3.0 mm Hg vs diltiazem SR; MD -4.0/-3.5 mm Hg vs hydrochlorothiazide). Combined diltiazem SR and hydrochlorothiazide achieved goal BP in 75% at highest doses vs 57% with diltiazem SR and 50% with hydrochlorothiazide alone.
Synapse has enriched 10 related papers. Consider them for comparative context: